Last night at the Andrew W. Mellon Auditorium, the Parker Foundation celebrated the passage of the 21st Century Cures Act with ACT for NIH, Friends of Cancer Research, and the Economic Innovation Group. Among the attendees were entrepreneur and philanthropist Sean Parker and his wife Alexandra Parker; Sen. Mark Warner; Rep. Fred Upton and his…
Executive Summary Topics on the table include the new 21st Century Cures law, PDUFA VI, the Trump Administration and more. Friends of Cancer Research CEO Jeff Allen sits down with Ramsey Baghdadi to discuss passage of the 21st Century Cures Act – signed into law by President Obama Dec. 13; implementation of the measure…
Ellen V. Sigal, PhD, Chair and Founder of Friends of Cancer Research (Friends) began the annual meeting with a conversation with Douglas R. Lowy, MD, National Cancer Institute (NCI) Acting Director, and Robert M. Califf, MD, U.S. Food and Drug Administration (FDA) Commissioner. “Cancer research is where it is today because of long-term funding…
As cancer care evolves into a field where genomic testing is used routinely to pinpoint diagnoses and determine treatments for specific subpopulations, a growing number of molecular tests are becoming available to oncologists. Invited speakers examined issues related to the role of these tests in precision medicine at a Senate briefing on Capitol Hill sponsored…
The Senate approved the 21st Century Cures Act, a wide-ranging bill that authorizes $1.8 billion over seven years for cancer research as well as $500 million over the next decade for FDA to streamline drug and device approval processes. The bill, which passed by a vote of 94-5 on Dec. 7, authorizes $4.976 billion…
A new era in research at George Washington University began with the official opening of the GW Cancer Center Wednesday evening. With a focus on patient care and collaboration, the GWCC will be a beacon of innovation, said President Steven Knapp. “If you’re looking for interdisciplinary work that’s really going to shape the future…
With self-congratulatory zeal and smiles all around, huge bipartisan majorities in Congress have just passed legislation to speed the discovery of cures for killer diseases. At the same time, Republican leaders have been devising a strategy to undo the Affordable Care Act, which has done more than any law in a generation to treat people…
The U.S. Senate voted overwhelmingly on Wednesday to support sweeping legislation that will reshape the way the Food and Drug Administration approves new medicines. It will also provide funding for cancer and Alzheimer’s research, help fight the opioid epidemic, expand access to mental health treatment and advance research into precision medicine. Two years…
More than 200 people celebrated the opening of the GW Cancer Center Wednesday night in the Science and Engineering Hall. The center features new labs and equipment on the eighth floor of the Science and Engineering Hall. Before the ribbon cutting ceremony, leaders in the University and the center said that this location will…
Executive Summary Enrolling patients with stable brain metastases, HIV-positive status and other traditionally excluded groups could give sponsors a marketing edge, but trials should be designed to examine drug effects on such populations separately from the more traditional study population, stakeholders said. Broadening the eligibility criteria for cancer clinical trials could enable…
